Showing 2211-2220 of 3282 results for "".
A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.Risks of Multiple Primary Melanomas
https://practicaldermatology.com/topics/practice-management/risks-of-multiple-primary-melanomas/21058/Studies offer clarity on risks and patterns after diagnosis, as well as survival outcomes.Dermatology and the ICD-10 Code Conundrum
https://practicaldermatology.com/topics/practice-management/dermatology-and-the-icd-10-code-conundrum/21372/EHRs equipped for ICD-10 can make the impending transition smooth for any practice.Dealing With Unhappy Cosmetic Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dealing-with-unhappy-cosmetic-patients/23870/Tips on avoiding and appeasing difficult patients.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muStaphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.Hidradenitis Suppurativa: Focus on Diagnosis
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-focus-on-diagnosis/23816/An expert discusses unmet needs in identifying and treating this inflammatory disease.DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorCurrents: Targeted Opportunities
https://practicaldermatology.com/topics/practice-management/currents-targeted-opportunities/23097/Reach your goals in dermatology practice.To Sell or Not To Sell Your Practice…
https://practicaldermatology.com/topics/practice-management/to-sell-or-not-to-sell-your-practice/20408/